Vetter’s Roth Appointed to Fraunhofer Advisory Board

The posting brings Vetter expertise to prestigious R&D think tank.

Dr. Claudia Roth, Vice President of Vetter’s department of Innovation Management, was recently appointed to the Advisory Board of the Fraunhofer Institute for Manufacturing Engineering and Automation IPA. Over the next two years, Dr. Roth will be active in the German research group’s Process Industry business unit in Stuttgart. 
According to Vetter, cooperation among scientific research organizations, including Germany’s preeminent Fraunhofer-Gesellschaft, is an integral part of Vetter's innovation management strategy. “Sharing information with the sciences offers significant stimuli, particularly in the field of manufacturing,” said Dr. Roth. “This appointment is particularly exciting since it allows me to contribute knowledge I gained as a member of the Advisory Board of the Fraunhofer Institute for Manufacturing Engineering and Automation IPA.” The IPA’s Process Industry business unit researches how programs such as Industry 4.0 can be applied to processes in the pharmaceutical sector. 

Dr. Roth has been with Vetter for years, occupying several important roles. Most recently she played a major role launching the Vetter Development Service and leading the Vetter Development Service operations near Chicago from 2009 to 2014. 

Vetter says it is currently working on securing its future business trajectory, employing a 360-degree process involving internal and external impulses to find as Vetter described it “new incitements” for innovation. These ideas, explained Vetter, are integrated in a multi-stage innovation process, which starts with a potential appraisal and ends with a possible market launch. “The focus,” says Vetter, “is on new manufacturing processes and technologies, additional services and innovative application systems to increase customer value.” 

 

Guy Tiene

Guy supports the success of life science organizations by identifying synergies across research, content, marketing and communications resources to drive value for clients. With over 30 years of education and marketing experience and 18 years in the life sciences alone, Guy leads our editorial standards for client content, Pharma’s Almanac and Nice Insight research-based industry content as well as external communications for clients. Having served as head of global marketing and communications for a CMO, he also brings critical insight and guidance to all communications. Guy holds a Masters degree from Columbia University.

Q: